TP53 and anaplastic large cell lymphoma: Genomic and functional characterization of systemic ALK-negative anaplastic large cell lymphoma (sALCL) has revealed the importance of STAT3 activation, MYC expression, PRDM1/TP53 abnormalities and recurrent structural variants involving the DUSP22 and TP63 loci [6–9].